Corteva, Inc. (NYSE: CTVA) announces that Executive Vice President and Chief Financial Officer, David Johnson, and Executive Vice President and Chief Technology and Digital Officer, Sam...

Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune dysregulation that drive...

ImageTrend announced the winners of its 2025 Hooley Awards during a celebration at the 17th annual ImageTrend Connect Conference. Now in its 10th year, the Hooley Awards honor industry leaders who...

Study Administered CRISPR genetically engineered CISH-knockout Tumor Infiltrating Lymphocytes as a Model System to Evaluate the Safety and Efficacy of this Classically Undruggable Intracellular Target

The webinar will explore PC111, a novel monoclonal antibody drug candidate with the potential to transform the treatment landscape for Pemphigus Vulgaris and Stevens-Johnson Syndrome/Toxic...